Anti-CRDL2/ CHRDL2/ BNF1 functional antibody

Anti-CRDL2/ CHRDL2/ BNF1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CHRDL2/CHRDL2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0778-Ab-1/ GM-Tg-hg-SE0778-Ab-2Anti-Human CHRDL2 monoclonal antibodyHuman
GM-Tg-rg-SE0778-Ab-1/ GM-Tg-rg-SE0778-Ab-2Anti-Rat CHRDL2 monoclonal antibodyRat
GM-Tg-mg-SE0778-Ab-1/ GM-Tg-mg-SE0778-Ab-2Anti-Mouse CHRDL2 monoclonal antibodyMouse
GM-Tg-cynog-SE0778-Ab-1/ GM-Tg-cynog-SE0778-Ab-2Anti-Cynomolgus/ Rhesus macaque CHRDL2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0778-Ab-1/ GM-Tg-felg-SE0778-Ab-2Anti-Feline CHRDL2 monoclonal antibodyFeline
GM-Tg-cang-SE0778-Ab-1/ GM-Tg-cang-SE0778-Ab-2Anti-Canine CHRDL2 monoclonal antibodyCanine
GM-Tg-bovg-SE0778-Ab-1/ GM-Tg-bovg-SE0778-Ab-2Anti-Bovine CHRDL2 monoclonal antibodyBovine
GM-Tg-equg-SE0778-Ab-1/ GM-Tg-equg-SE0778-Ab-2Anti-Equine CHRDL2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0778-Ab-1/ GM-Tg-hg-SE0778-Ab-2; GM-Tg-rg-SE0778-Ab-1/ GM-Tg-rg-SE0778-Ab-2;
GM-Tg-mg-SE0778-Ab-1/ GM-Tg-mg-SE0778-Ab-2; GM-Tg-cynog-SE0778-Ab-1/ GM-Tg-cynog-SE0778-Ab-2;
GM-Tg-felg-SE0778-Ab-1/ GM-Tg-felg-SE0778-Ab-2; GM-Tg-cang-SE0778-Ab-1/ GM-Tg-cang-SE0778-Ab-2;
GM-Tg-bovg-SE0778-Ab-1/ GM-Tg-bovg-SE0778-Ab-2; GM-Tg-equg-SE0778-Ab-1/ GM-Tg-equg-SE0778-Ab-2
Products NameAnti-CHRDL2 monoclonal antibody
Formatmab
Target NameCHRDL2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CHRDL2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0778-Ag-1Recombinant multi-species CRDL2/ CHRDL2/ BNF1 protein


    Target information

    Target IDGM-SE0778
    Target NameCHRDL2
    Gene ID25884,69121,308854,693657,609312,101093460,533631,100065017
    Gene Symbol and Synonyms1810022C01Rik,BNF1,CHL2,CHRDL2
    Uniprot AccessionQ6WN34
    Uniprot Entry NameCRDL2_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000054938
    Target ClassificationN/A

    The target: CHRDL2, gene name: CHRDL2, also named as BNF1, CHL2. This gene encodes a member of the chordin family of proteins. Chordin family members are secreted proteins that share a cysteine-rich pro-collagen repeat domain and associate with members of the transforming growth factor beta superfamily. In vitro assays demonstrate a direct interaction between the encoded protein and human activin A. This gene is expressed in many tissues including osteoblasts, where it is differentially expressed during differentiation. In addition, its expression is upregulated in human osteoarthritic joint cartilage, suggesting a role in adult cartilage regeneration. [provided by RefSeq, Jan 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.